Altogether, these data point to the increased abundance of TGM2+ AT myeloid cells in HFD as a candidate player in regulating AT inflammation during obesity scenarios with metabolic dysfunction. The gene discussed is TGM2; the disease is obesity due to melanocortin 4 receptor deficiency.